wuhaf1 | 42014
SARS-CoV-2 ab qn nucleocapsid protein
Keywords
Coronavirus, COVID-19, infection, NCP, nucleocapsid, SARS-CoV-2 antibodies
| Material |
|
|
| Stability | 1 week / 2-8°C | |
| Duration | 2 days | |
| Frequency | 5 x per week (monday - friday) | |
| Method | Electrochemiluminescence Immunoassay (ECLIA) | |
| Price | CHF 37.80 | |
| Tariff | 37.80 TP | |
| LA position | 3189.00 | |
| Designation | SARS-Coronavirus-2 (SARS-CoV-2), Ig oder | |
| Executing laboratory | External laboratory |
Reference values
| Value | Sex |
|---|---|
| < 0.7 COI | f+m |
| Borderline:1.0-1.2 COI | f+m |
| Positive:> 1.0 COI | f+m |
Team of consultants
|
Dr. sc. nat. ETH, FAMH Specialist in laboratory medicine, main fields medical microbiology, immunology
Diana Ciardo
Head of Specialty laboratories
|
Head of Specialty laboratories | T |
|
|
PhD
Christiane Beckmann
FAMH Specialist in laboratory medicine, main field medical microbiology
|
FAMH Specialist in laboratory medicine, main field medical microbiology | T |
|
|
MD
Olivier Dubuis
FAMH Specialist in laboratory medicine, main field medical microbiology
|
FAMH Specialist in laboratory medicine, main field medical microbiology | T |
|
|
MSc ETH Mikrobiology and Immunology
Claudio Castelberg
FAMH Specialist in laboratory medicine, main field medical microbiology
|
FAMH Specialist in laboratory medicine, main field medical microbiology | T |
|
|
PhD
Kerstin Narr
FAMH Specialist in laboratory medicine, main field medical microbiology
|
FAMH Specialist in laboratory medicine, main field medical microbiology | T |
|